The United States and Switzerland on Friday unveiled a major trade framework aimed at strengthening bilateral economic ties. Under the agreement, Washington will slash tariffs on imported Swiss goods to 15%, a substantial reduction from the existing average rate of 39%. In return, Swiss firms have committed to invest $200 billion in the United States by the end of 2028.

The framework, which also involves Liechtenstein, is expected to be finalized by the first quarter of 2026, according to a statement from the White House. The deal is positioned as a move to eliminate long-standing trade barriers and expand market access for both economies.

US Trade Representative Jamieson Greer described the agreement as a breakthrough that will open new markets for American products. He highlighted that the significant Swiss investment—particularly in pharmaceuticals and other strategic sectors—will help reduce the US deficit and create thousands of jobs across the country.

Of the total $200 billion commitment, at least $67 billion is expected to flow into the US in 2026 alone. The pledged investments also include previously announced commitments such as $50 billion from Roche and $23 billion from Novartis, reflecting Switzerland’s strong corporate presence in the American pharmaceutical and healthcare industries.

The agreement signals growing cooperation between the two nations across trade, investment, and strategic industries, with both sides expecting material benefits over the next several years.